You've probably noticed that a lot has changed from last season. Gone is the Team Captain and total starts per driver restriction from the roster building process. In its place is a new salary based system. This new roster selection process lets you pick any driver each race of the season.
BCR-ABL testing is ordered when a doctor suspects that a person has CML or Ph positive ALL. Initial testing may be indicated when a person has nonspecific symptoms such as fatigue, weight loss, joint or bone pain, and/or an enlarged spleen or as a follow-up to abnormal findings on a CBC.
Conclusion: there was no difference of BCR-ABL transcript level among sokal prognostic score risk groups in chronic phase CML patients treated with Imatinib. Key words: CML, Imatinib, Sokal prognostic score, BCR-ABL/G6PDH transcript.INTRODUCTION Chronic myeloid leukemia (CML) is the first malignancy associated with a specific chromosome abnormality with an annual incidence of 1 to 2 cases per 100.000 per year and a median onset in the fifth or sixth decade of life.t the time of diagnosis, the characteristic of subject in this study was based on Sokal prognostic risk clasification can be seen in Table 1 Table 2). The rates of major MR were 1 (10% of low risk group), 1 (8.3%), and 1 (5.5%) in low-, intermediate-, and high-risk group patients, respectively (Table 3).